| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.29 | 0.006 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.23 | 0.4 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.2 | 0.006 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.18 | 0.0006 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.1 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.17 | 0.6 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.17 | 0.002 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.16 | 0.003 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.15 | 0.002 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.14 | 0.006 |